OCX-909

N/A

Report date: 2026/03/13 20:02:36

Base Information

Drug NameOCX-909

Drug Alias NameOCX-909

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionChitinase-3-like protein 1 inhibitorsCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors

TargetsChitinase-3-like protein 1Cytotoxic T-Lymphocyte-Associated Antigen 4

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesElkurt Inc

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A